Connect with us

Health

Dr. Peter Hotez predicts rampant spread of diseases once Trump takes office

Published

5 minute read

From LifeSiteNews

By Antonino Cambria

Dr. Peter Hotez says it will be ‘dangerous’ if the Senate confirms Robert F. Kennedy Jr. as the Secretary of Health and Human Services.

Prominent “vaccine scientist” Dr. Peter Hotez issued an eerie warning during an interview this week, listing a litany of diseases that may begin to spread starting on January 21, President-elect Donald Trump’s first full day in office.

Speaking with Nicole Wallace on MSNBC’s Deadline White House about how supposedly “dangerous” it would be for the country if the Senate confirms Robert F. Kennedy Jr. as Secretary of Health and Human Services (HHS), Hotez began warning of diseases that will start to spread on January 21 while slamming vaccine skeptics. Hotez has a long history of attacking “anti-vaxxers” who have raised legitimate concerns about COVID and other vaccines.

“We have some big picture stuff coming down the pike starting on January 21. Mr. (Mike) Bloomberg mentioned H5N1 that I’m really worried about,” Hotez said. “It’s all over wild birds on the western part of the United States and going up in the north. It’s getting into the poultry, we’re seeing sporadic human cases, no human-to-human transmission yet, but that could happen. It’s in the cattle, it’s in the milk. And that’s just the beginning.

“We have another major coronavirus likely brewing in Asia; we’ve had Sars in 2002, Sars2, COVID-19 in 2019. And we know these viruses are jumping from bats to people thousands of times a year.”

“But there’s still more; we know that we have a big problem with mosquito-transmitted viruses all along the Gulf Coast. Where I am here in Texas, we’re expecting dengue and possibly Zika virus coming back or Oro Pouche virus, maybe even yellow fever, and there’s more. Then we have this sharp rise in vaccine-preventable diseases going up because, in part, the anti-vaccine activists,” Hotez said.

The scientist then reiterated that we might start to see these outbreaks on January 21 under the new Trump administration.

“All that’s gonna come crashing down on January 21st on the Trump administration. We need a really, really good team to be able to handle this,” Hotez said.

There have been several responses to Hotez’s strange comments, including by cardiologist and leading COVID establishment critic Dr. Peter McCullough, who said during an appearance on Live from Studio 6B on Real America’s Voice that Hotez and “vaccine lobbyists” are pushing an “agenda of fear.”

“To lay it down and say it’s all gonna happen the day Trump takes office, you can tell what the agenda here is. There’s an agenda of fear being pushed by the vaccine lobbyists to constantly keep Americans in fear about the next viral threat so they can hold power and because they know in their minds that the only thing they’ll offer is more vaccines,” McCullough said.

However, he did offer a response to the backlash from his statements on X, saying his comments were being misinterpreted by “extremist media.”

“(I) outlined the tough infectious disease challenges the Trump appointees will face and inherit when they begin in January. They twisted it to claim we will launch new viruses at them, as totally ridiculous as that sounds,” Hotez wrote.

Hotez was a major proponent of the COVID vaccines and has slammed vaccine skeptics. In a 2022 World Health Organization (WHO) video about “misinformation” surrounding the COVID vaccine, he called those who had concerns about the vaccine a major killing force.”

Last year, after an appearance by RFK Jr. on Joe Rogan’s podcast in which they discussed his concerns over vaccines, Hotez blasted them for “misinformation” in an X post. His post prompted Rogan to challenge him to debate RFK Jr. on his show. While RFK Jr. agreed to the debate, Hotez never responded.

 

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Alberta

Alberta’s move to ‘activity-based funding’ will improve health care despite naysayer claims

Published on

From the Fraser Institute

By Nadeem Esmail

After the Smith government recently announced its shift to a new approach for funding hospitals, known as “activity-based funding” (ABF), defenders of the status quo in Alberta were quick to argue ABF will not improve health care in the province. Their claims are simply incorrect. In reality, based on the experiences of other better-performing universal health-care systems, ABF will help reduce wait times for Alberta patients and provide better value-for-money for taxpayers.

First, it’s important to understand Alberta is not breaking new ground with this approach. Other developed countries shifted to the ABF model starting in the early 1990s.

Indeed, after years of paying their hospitals a lump-sum annual budget for surgical care (like Alberta currently), other countries with universal health care recognized this form of payment encouraged hospitals to deliver fewer services by turning each patient into a cost to be minimized. The shift to ABF, which compensates hospitals for the actual services they provide, flips the script—hospitals in these countries now see patients as a source of revenue.

In fact, in many universal health-care countries, these reforms began so long ago that some are now on their second or even third generation of ABF, incorporating further innovations to encourage an even greater focus on quality.

For example, in Sweden in the early 1990s, counties that embraced ABF enjoyed a potential cost savings of 13 per cent over non-reforming counties that stuck with budgets. In Stockholm, one study measured an 11 per cent increase in hospital activity overall alongside a 1 per cent decrease in costs following the introduction of ABF. Moreover, according to the study, ABF did not reduce access for older patients or patients with more complex conditions. In England, the shift to ABF in the early to mid-2000s helped increase hospital activity and reduce the cost of care per patient, also without negatively affecting quality of care.

Multi-national studies on the shift to ABF have repeatedly shown increases in the volume of care provided, reduced costs per admission, and (perhaps most importantly for Albertans) shorter wait times. Studies have also shown ABF may lead to improved quality and access to advanced medical technology for patients.

Clearly, the naysayers who claim that ABF is some sort of new or untested reform, or that Albertans are heading down an unknown path with unmanageable and unexpected risks, are at the very least uninformed.

And what of those theoretical drawbacks?

Some critics claim that ABF may encourage faster discharges of patients to reduce costs. But they fail to note this theoretical drawback also exists under the current system where discharging higher-cost patients earlier can reduce the drain on hospital budgets. And crucially, other countries have implemented policies to prevent these types of theoretical drawbacks under ABF, which can inform Alberta’s approach from the start.

Critics also argue that competition between private clinics, or even between clinics and hospitals, is somehow a bad thing. But all of the developed world’s top performing universal health-care systems, with the best outcomes and shortest wait times, include a blend of both public and private care. No one has done it with the naysayers’ fixation on government provision.

And finally, some critics claim that, under ABF, private clinics will simply focus on less-complex procedures for less-complex patients to achieve greater profit, leaving public hospitals to perform more complex and thus costly surgeries. But in fact, private clinics alleviate pressure on the public system, allowing hospitals to dedicate their sophisticated resources to complex cases. To be sure, the government must ensure that complex procedures—no matter where they are performed—must always receive appropriate levels of funding and similarly that less-complex procedures are also appropriately funded. But again, the vast and lengthy experience with ABF in other universal health-care countries can help inform Alberta’s approach, which could then serve as an example for other provinces.

Alberta’s health-care system simply does not deliver for patients, with its painfully long wait times and poor access to physicians and services—despite its massive price tag. With its planned shift to activity-based funding, the province has embarked on a path to better health care, despite any false claims from the naysayers. Now it’s crucial for the Smith government to learn from the experiences of others and get this critical reform right.

Nadeem Esmail

Senior Fellow, Fraser Institute
Continue Reading

Autism

NIH, CMS partner on autism research

Published on

From The Center Square

By 

Officials at the the National Institutes of Health and the Centers for Medicare & Medicaid Services announced a partnership Wednesday to research “root causes of autism spectrum disorder.”

As part of the project, NIH will build a real-world data platform enabling advanced research across claims data, electronic medical records and consumer wearables, according to the agencies.

“We’re using this partnership to uncover the root causes of autism and other chronic diseases,” said HHS Secretary Robert F. Kennedy Jr. “We’re pulling back the curtain – with full transparency and accountability – to deliver the honest answers families have waited far too long to hear.”

CMS and NIH will start this partnership by establishing a data use agreement under CMS’ Research Data Disclosure Program focused on Medicare and Medicaid enrollees with a diagnosis of autism spectrum disorder or ASD.

“This partnership is an important step in our commitment to unlocking the power of real-world data to inform public health decisions and improve lives,” NIH Director Dr. Jay Bhattacharya said. “Linking CMS claims data with a secure real-world NIH data platform, fully compliant with privacy and security laws, will unlock landmark research into the complex factors that drive autism and chronic disease – ultimately delivering superior health outcomes to the Americans we serve.”

Researchers will focus on autism diagnosis trends over time, health outcomes from specific medical and behavioral interventions, access to care and disparities by demographics and geography and the economic burden on families and healthcare systems, according to a news release.

Continue Reading

Trending

X